250 related articles for article (PubMed ID: 10779352)
1. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins.
Leone G; Nuckolls F; Ishida S; Adams M; Sears R; Jakoi L; Miron A; Nevins JR
Mol Cell Biol; 2000 May; 20(10):3626-32. PubMed ID: 10779352
[TBL] [Abstract][Full Text] [Related]
2. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
3. Differential activities of E2F family members: unique functions in regulating transcription.
Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor.
Meloni AR; Smith EJ; Nevins JR
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9574-9. PubMed ID: 10449734
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
6. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
7. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus.
Adams MR; Sears R; Nuckolls F; Leone G; Nevins JR
Mol Cell Biol; 2000 May; 20(10):3633-9. PubMed ID: 10779353
[TBL] [Abstract][Full Text] [Related]
8. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation.
Ikeda MA; Jakoi L; Nevins JR
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3215-20. PubMed ID: 8622916
[TBL] [Abstract][Full Text] [Related]
9. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
11. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth.
Smith EJ; Leone G; Nevins JR
Cell Growth Differ; 1998 Apr; 9(4):297-303. PubMed ID: 9563849
[TBL] [Abstract][Full Text] [Related]
12. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
Kastner A; Espanel X; Brun G
Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members.
Vairo G; Livingston DM; Ginsberg D
Genes Dev; 1995 Apr; 9(7):869-81. PubMed ID: 7705662
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
Arroyo M; Raychaudhuri P
Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
[TBL] [Abstract][Full Text] [Related]
15. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
Nakajima Y
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
[TBL] [Abstract][Full Text] [Related]
16. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
17. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
18. Subunit composition determines E2F DNA-binding site specificity.
Tao Y; Kassatly RF; Cress WD; Horowitz JM
Mol Cell Biol; 1997 Dec; 17(12):6994-7007. PubMed ID: 9372931
[TBL] [Abstract][Full Text] [Related]
19. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression.
Tommasi S; Pfeifer GP
Mol Cell Biol; 1995 Dec; 15(12):6901-13. PubMed ID: 8524257
[TBL] [Abstract][Full Text] [Related]
20. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a.
Chen D; Opavsky R; Pacal M; Tanimoto N; Wenzel P; Seeliger MW; Leone G; Bremner R
PLoS Biol; 2007 Jul; 5(7):e179. PubMed ID: 17608565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
